Related Experiment Videos
Evaluation of a continuous oestrogen-progestogen regimen for climacteric complaints
Maturitas
|August 1, 1982
Summary
Continuous estrogen-progestogen therapy effectively reduced menopausal symptoms like hot flashes. Endometrial biopsies showed inactive mucosa, indicating this regimen is a safe alternative for post-menopausal hormone therapy.
Area of Science:
- Gynecology
- Menopause Management
- Hormone Therapy
Background:
- Menopausal hormone therapy aims to alleviate symptoms and maintain quality of life.
- Continuous combined hormone therapy is one regimen option.
Purpose of the Study:
- To evaluate the efficacy and safety of a continuous estrogen-progestogen regimen in managing menopausal symptoms.
- To assess endometrial response and bleeding patterns during 12 months of therapy.
Main Methods:
- 26 patients received continuous estrogen-progestogen therapy for 12 months.
- Data collected included subjective complaints, endometrial histopathology, vaginal cytology, and bleeding patterns.
- Karyopyknotic index was used to assess estrogenic activity.
Main Results:
- Significant reduction in hot flushes and sweats observed.
- Endometrial evaluation revealed mostly inactive-atrophic mucosa.
- Vaginal bleeding was minimal in post-menopausal women and an unreliable indicator of endometrial status.
- Karyopyknotic index was a poor indicator of estrogenic activity.
Conclusions:
- Continuous estrogen-progestogen therapy is a viable and effective option for post-menopausal women.
- The regimen demonstrates safety with minimal endometrial changes and reduced menopausal symptoms.